BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 21593747)

  • 1. Adverse drug reactions: moving from chance to science.
    Haller C; James LP
    Clin Pharmacol Ther; 2011 Jun; 89(6):761-4. PubMed ID: 21593747
    [No Abstract]   [Full Text] [Related]  

  • 2. "Black box" warnings and drug surveillance.
    Menendez R
    J Allergy Clin Immunol; 2007 Mar; 119(3):759; author reply 759-60. PubMed ID: 17336622
    [No Abstract]   [Full Text] [Related]  

  • 3. Improving the reporting of adverse drug reactions in the hospital setting.
    Pushkin R; Frassetto L; Tsourounis C; Segal ES; Kim S
    Postgrad Med; 2010 Nov; 122(6):154-64. PubMed ID: 21084792
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How should we react to adverse drug reactions?
    Ferner RE; Beard K
    Postgrad Med J; 2011 Feb; 87(1024):81-2. PubMed ID: 21303818
    [No Abstract]   [Full Text] [Related]  

  • 5. Using computer technology to detect, measure, and prevent adverse drug events.
    Gardner RM; Evans RS
    J Am Med Inform Assoc; 2004; 11(6):535-6. PubMed ID: 15317740
    [No Abstract]   [Full Text] [Related]  

  • 6. Short patent lives jeopardize drug and patient safety.
    Hondeghem LM; De Clerck F; Camm J
    J Cardiovasc Pharmacol; 2007 Oct; 50(4):353-7. PubMed ID: 18049301
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse drug reactions in hospital and ambulatory care settings identified using a large administrative database.
    Kane-Gill SL; Van Den Bos J; Handler SM
    Ann Pharmacother; 2010 Jun; 44(6):983-93. PubMed ID: 20442350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods for drug safety signal detection in longitudinal observational databases: LGPS and LEOPARD.
    Schuemie MJ
    Pharmacoepidemiol Drug Saf; 2011 Mar; 20(3):292-9. PubMed ID: 20945505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Failure to recognize adverse drug reactions despite warnings.
    Griffin JP
    Adverse Drug React Toxicol Rev; 1999 Mar; 18(1):1-3. PubMed ID: 10401518
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacogenomics and active surveillance for serious adverse drug reactions in children.
    Loo TT; Ross CJ; Sistonen J; Visscher H; Madadi P; Koren G; Hayden MR; Carleton BC
    Pharmacogenomics; 2010 Sep; 11(9):1269-85. PubMed ID: 20860467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug safety--important to us all!
    Böttiger LE
    J Intern Med; 2001 Oct; 250(4):269-70. PubMed ID: 11576314
    [No Abstract]   [Full Text] [Related]  

  • 12. Adverse drug reactions in utero: perspectives on teratogens and strategies for the future.
    Mitchell AA
    Clin Pharmacol Ther; 2011 Jun; 89(6):781-3. PubMed ID: 21593753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bayesian hierarchical modeling for detecting safety signals in clinical trials.
    Xia HA; Ma H; Carlin BP
    J Biopharm Stat; 2011 Sep; 21(5):1006-29. PubMed ID: 21830928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling, building and evaluating an ontology for the automatic characterization of adverse drug effects during pharmacovigilance.
    Duclos C; Soualmia LF; Krivine S; Jamet A; Lillo-Louët A
    Stud Health Technol Inform; 2010; 160(Pt 2):1005-9. PubMed ID: 20841835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low quality of reporting adverse drug reactions in paediatric randomised controlled trials.
    de Vries TW; van Roon EN
    Arch Dis Child; 2010 Dec; 95(12):1023-6. PubMed ID: 20551194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Meta-analysis and adverse drug reactions.
    Mittmann N; Liu BA; Knowles SR; Shear NH
    CMAJ; 1999 Apr; 160(7):987-8. PubMed ID: 10207335
    [No Abstract]   [Full Text] [Related]  

  • 17. Detection, verification, and quantification of adverse drug reactions.
    Stricker BH; Psaty BM
    BMJ; 2004 Jul; 329(7456):44-7. PubMed ID: 15231627
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medication-related adverse reactions and the elderly: a literature review.
    Atkin PA; Shenfield GM
    Adverse Drug React Toxicol Rev; 1995; 14(3):175-91. PubMed ID: 7492703
    [No Abstract]   [Full Text] [Related]  

  • 19. Submitting reports of adverse drug reactions to AJHP.
    Thompson CA
    Am J Hosp Pharm; 1994 Oct; 51(19):2358. PubMed ID: 7847399
    [No Abstract]   [Full Text] [Related]  

  • 20. Experts call for active surveillance of drug safety.
    Wadman M
    Nature; 2007 Mar; 446(7134):358-9. PubMed ID: 17377551
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.